These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites. Chawdhury ASMMR; Shamsi SA; Miller A; Liu A J Chromatogr A; 2021 Aug; 1651():462294. PubMed ID: 34098249 [TBL] [Abstract][Full Text] [Related]
23. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder. Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374 [TBL] [Abstract][Full Text] [Related]
24. Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects. Badawy AA Int J Tryptophan Res; 2017; 10():1178646917691938. PubMed ID: 28469468 [TBL] [Abstract][Full Text] [Related]
25. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms. Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558 [TBL] [Abstract][Full Text] [Related]
26. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain. Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717 [TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease. Mazarei G; Leavitt BR J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892 [TBL] [Abstract][Full Text] [Related]
29. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease. Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497 [TBL] [Abstract][Full Text] [Related]
30. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression. Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH Neuropsychopharmacology; 2020 May; 45(6):998-1007. PubMed ID: 31940661 [TBL] [Abstract][Full Text] [Related]
31. Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices. Dale WE; Dang Y; Brown OR Free Radic Biol Med; 2000 Jul; 29(2):191-8. PubMed ID: 10980407 [TBL] [Abstract][Full Text] [Related]
32. The possible role of the kynurenine pathway in adolescent depression with melancholic features. Gabbay V; Klein RG; Katz Y; Mendoza S; Guttman LE; Alonso CM; Babb JS; Hirsch GS; Liebes L J Child Psychol Psychiatry; 2010 Aug; 51(8):935-43. PubMed ID: 20406333 [TBL] [Abstract][Full Text] [Related]
33. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336 [TBL] [Abstract][Full Text] [Related]
34. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice. Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279 [TBL] [Abstract][Full Text] [Related]
35. Kynurenine pathway changes in late-life depression. Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078 [TBL] [Abstract][Full Text] [Related]
36. Simultaneous detection of stable isotope-labeled and unlabeled L-tryptophan and of its main metabolites, L-kynurenine, serotonin and quinolinic acid, by gas chromatography/negative ion chemical ionization mass spectrometry. Sano M; Ferchaud-Roucher V; Nael C; Aguesse A; Poupeau G; Castellano B; Darmaun D J Mass Spectrom; 2014 Feb; 49(2):128-35. PubMed ID: 24677305 [TBL] [Abstract][Full Text] [Related]
37. Increased fatty acid oxidation and mitochondrial proliferation in liver are associated with increased plasma kynurenine metabolites and nicotinamide levels in normolipidemic and carnitine-depleted rats. Lindquist C; Bjørndal B; Lund A; Slettom G; Skorve J; Nygård O; Svardal A; Berge RK Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158543. PubMed ID: 31676443 [TBL] [Abstract][Full Text] [Related]
38. Kynurenine pathway changes in late-life depression with memory deficit. Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300 [TBL] [Abstract][Full Text] [Related]
39. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958 [TBL] [Abstract][Full Text] [Related]
40. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Thomas SR; Stocker R Redox Rep; 1999; 4(5):199-220. PubMed ID: 10731095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]